Veracyte (VCYT) Gross Margin (2012 - 2026)

Veracyte has disclosed Gross Margin across 15 years of filings, most recently posting 72.74% for Q1 2026.

• Gross Margin for Q1 2026 came in at 72.74%, up 328.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 70.92% (up 290.0% YoY), and the FY2025 annual result was 70.1%, up 322.0% from the prior year.
• Gross Margin came in at 72.74% for Q1 2026 at Veracyte, roughly flat from 72.51% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 72.74% in Q1 2026 to a low of 61.8% in Q2 2023.
• The 5-year median for Gross Margin is 68.09% (2024), against an average of 67.54%.
• Across the five-year window, Gross Margin jumped 936 bps in 2022 and sank 526 bps in 2023, its largest moves.
• Veracyte's Gross Margin stood at 69.95% in 2022, then dropped by 6 bps to 65.98% in 2023, then advanced by 1 bps to 66.39% in 2024, then advanced by 9 bps to 72.51% in 2025, then rose by 0 bps to 72.74% in 2026.
• The last three Gross Margin figures came in at 72.74% (Q1 2026), 72.51% (Q4 2025), and 69.22% (Q3 2025), per Business Quant data.